Life Science Compliance Update



Off-Label Bills Garner Minimal Traction in Congress

Written by , Posted in Feature Article

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

Further muddying the off-label waters is the fact that Congress has introduced several bills, attempting to legislate off-label use. Both bills were initially introduced as attachments to the FDA reauthorization bill, but when House Democrats resisted, both sponsors pulled the bills as attachments. On July 12, 2017, the Subcommittee on Health held a brief hearing on both bills, giving industry and others a chance to speak on off-label promotion.

Gravityscan Badge
Menu Title